Previous 10 | Next 10 |
AquaBounty Technologies (NASDAQ: AQB ): Q1 GAAP EPS of -$0.18 beats by $0.01 . More news on: AquaBounty Technologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
MAYNARD, Mass., May 02, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a subsidiary of Intrexon Corporation (NASDAQ: XON...
MAYNARD, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a subsidiary of Intrexon Corporation (Nasdaq: X...
MAYNARD, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a subsidiary of Intrexon Corporation (Nasdaq: X...
Gainers: Vital Therapies (NASDAQ: VTL ) +199% . JMU Limited (NASDAQ: JMU ) +24% . Aehr Test Systems (NASDAQ: AEHR ) +22% . GEE Group (NYSEMKT: JOB ) +19% . ChinaNet Online Holdings (NASDAQ: CNET ) +15% . RumbleON (NASDAQ: RMBL ) +15% . Hancock Jaffe Laboratories (NASDAQ: HJLI )...
AquaBounty Technologies ( AQB -20.4% ) announced that it has commenced a proposed underwritten public offering of common stock of the Company. More news on: Intrexon Corporation, AquaBounty Technologies, Inc., Read more ...
AquaBounty Technologies (NASDAQ: AQB ) -23% on pricing stock offering. More news on: AquaBounty Technologies, Inc., Duluth Holdings Inc., Merrimack Pharmaceuticals, Inc., Stocks on the move, Read more ...
AquaBounty Technologies (NASDAQ: AQB ) has priced its public offering of 2,554,590 common shares at $2.25 per share yielding gross proceeds of ~$5.75M. More news on: AquaBounty Technologies, Inc., Healthcare stocks news, Consumer stocks news, Read more ...
MAYNARD, Mass., April 04, 2019 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (Nasdaq: AQB) (“AquaBounty” or the “Company”), a biotechnology company focused on enhancing productivity in the aquaculture market and a subsidiary of Intrexon Corporation (Nasdaq: X...
ADMA Biologics (NASDAQ: ADMA ) +46% as FDA approves ADMA Biologics' ASCENIV. More news on: ADMA Biologics, Inc., Sangamo Therapeutics, Inc., Riot Blockchain, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
AquaBounty Technologies Inc. Company Name:
AQB Stock Symbol:
NASDAQ Market:
AquaBounty Technologies Inc. Website:
Harvard, Massachusetts--(Newsfile Corp. - June 7, 2024) - The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that David F. Melbourn...
2024-05-16 10:00:03 ET Ben Klieve from Lake Street issued a price target of $2.00 for AQB on 2024-05-16 08:40:00. The adjusted price target was set to $2.00. At the time of the announcement, AQB was trading at $1.9951. The overall price target consensus is at $4.00 with ...
Harvard, Massachusetts--(Newsfile Corp. - May 15, 2024) - AquaBounty Technologies, Inc. (NASDAQ: AQB) ("AquaBounty" or the "Company"), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced the Company's financial results for the first qu...